Healthcare provider profile · identity verified

Samuel Edwin Donovan

Family Practice · PAWTUCKET, RI · NPI 1215433230

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	307	89
Atorvastatin Calcium	Atorvastatin Calcium	307	83
Rosuvastatin Calcium	Rosuvastatin Calcium	235	70
Levothyroxine Sodium	Levothyroxine Sodium	226	61
Lisinopril	Lisinopril	190	59
Losartan Potassium	Losartan Potassium	163	49
Metoprolol Succinate	Metoprolol Succinate	155	42
Omeprazole	Omeprazole	152	44
Gabapentin	Gabapentin	141	29
Metformin Hcl	Metformin Hcl	137	37
Albuterol Sulfate Hfa	Albuterol Sulfate	125	48
Hydrochlorothiazide	Hydrochlorothiazide	124	44
Clonazepam	Clonazepam	117	19
Alprazolam	Alprazolam	114	30
Oxycodone Hcl	Oxycodone Hcl	110	18
Simvastatin	Simvastatin	109	30
Famotidine	Famotidine	108	35
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	105	20
Zolpidem Tartrate	Zolpidem Tartrate	92	18
Trazodone Hcl	Trazodone Hcl	88	26
Eliquis	Apixaban	87	22
Fluticasone Propionate	Fluticasone Propionate	81	25
Montelukast Sodium	Montelukast Sodium	78	20
Tamsulosin Hcl	Tamsulosin Hcl	78	23
Jardiance	Empagliflozin	74	20
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	71	11
Escitalopram Oxalate	Escitalopram Oxalate	67	22
Duloxetine Hcl	Duloxetine Hcl	66	21
Pantoprazole Sodium	Pantoprazole Sodium	65	23
Diazepam	Diazepam	64	18
Atenolol	Atenolol	62	15
Metformin Hcl Er	Metformin Hcl	62	20
Allopurinol	Allopurinol	60	17
Furosemide	Furosemide	60	24
Clopidogrel	Clopidogrel Bisulfate	58	14
Sertraline Hcl	Sertraline Hcl	58	17
Potassium Chloride	Potassium Chloride	57	13
Tramadol Hcl	Tramadol Hcl	52	12
Morphine Sulfate Er	Morphine Sulfate	50	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	47	13
Valsartan	Valsartan	47	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	12
Alendronate Sodium	Alendronate Sodium	42	suppressed
Pravastatin Sodium	Pravastatin Sodium	42	14
Fluoxetine Hcl	Fluoxetine Hcl	39	13
Glipizide Er	Glipizide	39	12
Hydromorphone Hcl	Hydromorphone Hcl	39	suppressed
Januvia	Sitagliptin Phosphate	38	12
Mirtazapine	Mirtazapine	37	12
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	36	suppressed
Warfarin Sodium	Warfarin Sodium	36	14
Hydroxyzine Hcl	Hydroxyzine Hcl	35	suppressed
Ondansetron Odt	Ondansetron	34	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	34	11
Buspirone Hcl	Buspirone Hcl	33	suppressed
Morphine Sulfate	Morphine Sulfate	33	suppressed
Synthroid	Levothyroxine Sodium	33	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	33	suppressed
Eszopiclone	Eszopiclone	32	suppressed
Celecoxib	Celecoxib	31	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	30	suppressed
Pregabalin	Pregabalin	30	suppressed
Breyna	Budesonide/Formoterol Fumarate	29	suppressed
Ozempic	Semaglutide	29	suppressed
Ezetimibe	Ezetimibe	28	suppressed
Bupropion Hcl Sr	Bupropion Hcl	27	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	19
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	26	suppressed
Meloxicam	Meloxicam	26	suppressed
Lorazepam	Lorazepam	25	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	24	13
Lovastatin	Lovastatin	24	suppressed
Phenobarbital	Phenobarbital	24	suppressed
Finasteride	Finasteride	23	suppressed
Glipizide	Glipizide	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Enalapril Maleate	Enalapril Maleate	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Prednisone	Prednisone	20	11
Amoxicillin	Amoxicillin	19	11
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	19	suppressed
Fentanyl	Fentanyl	19	suppressed
Incruse Ellipta	Umeclidinium Bromide	19	suppressed
Glimepiride	Glimepiride	18	suppressed
Methylprednisolone	Methylprednisolone	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Baclofen	Baclofen	17	suppressed
Estradiol	Estradiol	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Nystatin	Nystatin	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	15
Ketoconazole	Ketoconazole	16	13
Ramipril	Ramipril	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Lasix	Furosemide	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Risperidone	Risperidone	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Clonidine	Clonidine	13	suppressed
Guanfacine Hcl Er	Guanfacine Hcl	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Carisoprodol	Carisoprodol	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Naproxen	Naproxen	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Epinephrine	Epinephrine	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Temazepam	Temazepam	11	suppressed
Topiramate	Topiramate	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error